Microbiome, metabolome, and transcriptome analyses in esophageal squamous cell carcinoma: insights into immune modulation by F. nucleatum
Authors:
Open Access
- 29 October 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Protein & Cell
- Vol. 16 (6) , 491-496
Abstract
Xue Zhang, Jing Han, Yudong Wang, Li Feng, Zhisong Fan, Yu Su, Wenya Song, Lan Wang, Long Wang, Hui Jin, Jiayin Liu, Dan Li, Guiying Li, Yan Liu, Jing Zuo,Keywords
This publication has 13 references indexed in Scilit:
- Intratumoral Microbiota Composition Regulates Chemoimmunotherapy Response in Esophageal Squamous Cell CarcinomaCancer Research, 2023
- Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine ProductionMicrobiology Spectrum, 2023
- The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancerCell Metabolism, 2022
- Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell CarcinomaNew England Journal of Medicine, 2022
- Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 studyThe Lancet, 2021
- Gut microbial metabolites facilitate anticancer therapy efficacy by modulating cytotoxic CD8+ T cell immunityCell Metabolism, 2021
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapyScience, 2020
- Periodontal disease, tooth loss, and risk of oesophageal and gastric adenocarcinoma: a prospective studyGut, 2020
- Oral microbiomes: more and more importance in oral cavity and whole bodyProtein & Cell, 2018
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patientsScience, 2018